Related Experiment Video
Updated: Aug 9, 2026

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Human Rights First: Reflections from the Mobilization on Human Rights and Drug Policy Conference
Veera Kankainen1, Tuukka Tammi2
1Sociology, Centre for Research on Addiction, Control, and Governance, University of Helsinki Faculty of Social Sciences, Helsinki, Finland.
Nordisk Alkohol- & Narkotikatidskrift : NAT
|August 8, 2026
Summary
Nordic countries
Area of Science:
- Public Health
- Human Rights Law
- Criminology
Background:
- Nordic countries utilize a dual-track model for drug policies, addressing drug use as either criminal or health issues.
- Human rights perspectives have been historically underrepresented in Nordic drug policy discussions.
- International civil society and harm reduction groups increasingly highlight human rights challenges in drug policies.
Purpose of the Study:
- To examine the integration of human rights into Nordic drug policy.
- To discuss the outcomes of a joint international conference on drug policy and human rights.
- To analyze current international and Nordic debates on drug policy as a human rights issue.
Main Methods:
- Review of conference notes from a 2026 international human rights-themed conference.
- Analysis of current international and Nordic drug policy debates.
- Discussion of human rights challenges in the context of drug use.
Main Results:
- A 2026 conference marked a significant increase in the prominence of human rights on the Nordic political agenda regarding drug policy.
- Civil society organizations representing people who use drugs are key actors in advocating for human rights in drug policy.
- There is a growing international and Nordic discourse on viewing drug policy through a human rights lens.
Conclusions:
- The integration of human rights perspectives is crucial for evolving Nordic drug policies.
- Increased engagement from civil society is vital for advancing human rights in drug policy.
- Further dialogue is needed to align Nordic drug policies with international human rights standards.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
International Nursing Organizations II
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
